We evaluated the impact of pharmacological inhibition of sEH on NPC phenotypic characteristics, such as lipid accumulation, cognitive impairment and other health parameters, such as weight gain/loss and survival. The gene discussed is EPHX2; the disease is Cognitive impairment.